SCHEMBL29893694

SCHEMBL29893694

c1ccc(-c2ccc3ccccc3c2)c(Nc2ccc3ccccc3c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ HPGD P15428 1/20 0.53
▸ GSTP1 P09211 1/20 0.48
▸ HDAC4 P56524 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ MAPK14 Q16539 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ MAPK10 P53779 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29104474 1.00 ALDH1A1 (0.53) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL4579836 0.95 ALDH1A1 (0.50) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL29830533 0.91 ALDH1A1 (0.47) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL24911621 0.91 ALDH1A1 (0.47) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL17733321 0.90 ALDH1A1 (0.55) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL24553505 0.90 ALDH1A1 (0.50) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL31680368 0.89 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10HPGDCYP1A2
SCHEMBL23142162 0.89 ALDH1A1 (0.53) ALDH1A1CYP3A4HSD17B10HPGDGSTP1
SCHEMBL17880363 0.89 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10HPGDCYP1A2
SCHEMBL27012225 0.89 GSTP1 (0.55) ALDH1A1CYP3A4HSD17B10HPGDGSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT TOSOH CORPORATION (JP) 2024-07-25 — — US disclosed
CN-117044428-A Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element 东曹株式会社 2023-11-10 — — CN disclosed
WO-2022211123-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE INJECTION LAYER, AND ORGANIC ELECTROLUMINESCENT ELEMENT 東ソー株式会社 2022-10-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT AXIN2, FZD7, SLC39A3 ALDH1A1 3265/4885CYP3A4 404/4885HSD17B10 3174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback